Pregnancy in neuromyelitis optica spectrum disorder: A multicenter study from South China

In this category you will have access to a database containing journal articles in the form of abstracts and full journal articles.
Post Reply
HSowalla
Forum Admin
Forum Admin
Posts: 25
Joined: Sat Sep 02, 2017 11:24 pm

Pregnancy in neuromyelitis optica spectrum disorder: A multicenter study from South China

Post by HSowalla » Sun Jun 24, 2018 3:57 pm

Pregnancy in neuromyelitis optica spectrum disorder: A multicenter study from South China
Journal of the Neurological Sciences 372 (2017) 152–156

Abstract:

Objective: This study aimed to assess the effect of pregnancy on the course of neuromyelitis optica spectrum disorder (NMOSD), and the effect of this disease on pregnancy outcomes.

Methods: Consecutive patients with NMOSD were recruited between September 2015 and April 2016 at an uotpatient clinic from four referral institutes in South China. Demographic, clinical, and pregnancy data were retrieved by questionnaires to analyze the association between NMOSD and pregnancy, as well as the potential risk factors for relapse.

Results: Among 249 patients with NMOSD, 55 had pregnancy-related attacks. The annual relapse rate in the first (3.20 ± 6.82) and second (3.25 ± 3.32) 3-month postpartum periods was marginally higher than that before pregnancy (1.44±0.92, p=0.682) and during pregnancy (1.23±1.32, p=0.758). The Kurtzke Expanded Disability Status Scale score increased from 1.55±0.38 before pregnancy to 2.88±2.14 at postpartum (p b 0.001). NMOSD significantly increased the premature birth rate in patients after disease onset (8.33%) compared with before disease onset (1.95%, p = 0.025). Multivariate analysis showed that negative anti-aquaporin-4 IgG, concomitance with autoimmune diseases/antibodies, and no treatment in remission were risk factors of recurrence.

Conclusion: Our study shows a significant association between pregnancy and NMOSD in the Chinese .
Larger scale prospective studies are warranted in the future.
Heather Sowalla

"Hope is being able to see that there is light despite all of the darkness."

+NMO AQP4
Preventative Treatment: Imuran (250mg) + Rituxan (2 Full Doses Every 3 Months)

Admin Teen & YA Support Group

Post Reply

Return to “NMO Library”